ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - pergolide as mesylate 0.25 mg - tablets - pergolide - pergolide is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of parkinson's disease with on-off phenomena. pergolide is indicated as monotherapy in the initial treatment period of parkinson's disease.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - apomorphine hydrochloride - תמיסה להזרקה\אינפוזיה - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - the treatment of disabling motor fluctuations ("on-off" phenomena) in patients with parkinson's disease which persist despite individually titrated treatment with levodopa (with a peripheral decarboxylase inhibitor) and/or other dopamine agonists.

ישראל - עברית - Ministry of Health

teva israel ltd - apomorphine hydrochloride - תמיסה להזרקה - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - the treatment of disabling motor fluctuations ( "on-off" phenomena) in patients with parkinson's disease which persist despite individually titrated treatment with levodopa ( with a peripheral decarboxylase inhibitor ) and/or other dopamine agonists.

ישראל - עברית - Ministry of Health

sanofi israel ltd - ramipril - טבליה - ramipril 1.25 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

ישראל - עברית - Ministry of Health

sanofi israel ltd - ramipril - טבליה - ramipril 2.5 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

ישראל - עברית - Ministry of Health

sanofi israel ltd - ramipril - טבליה - ramipril 5 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

ישראל - עברית - Ministry of Health

אלפא חברה לקוסמטיקה בעמ - מעגלת ומפרידה את הריסים

ישראל - עברית - Ministry of Health

אלפא חברה לקוסמטיקה בעמ - איפור

ישראל - עברית - Ministry of Health

אלפא חברה לקוסמטיקה בעמ - איפור

ישראל - עברית - Ministry of Health

אלפא חברה לקוסמטיקה בעמ - איפור